bf/NASDAQ:VIR_icon.jpeg

BIO:VIR

Vir Biotechnology

  • Stock

Last Close

6.95

22/11 21:00

Market Cap

1.14B

Beta: -

Volume Today

891.72K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-69.85M
-
-115.88M
65.90%
-174.68M
50.74%
-298.67M
70.98%
528.58M
276.98%
515.84M
2.41%
-615.06M
219.24%
depreciation and amortization
432K
-
2.76M
537.96%
4.52M
63.90%
5.44M
20.48%
5.81M
6.78%
6.78M
16.73%
19.45M
186.76%
deferred income tax
-10.92M
-
-480K
95.61%
14.66M
3,155%
-52K
100.35%
15.19M
29,303.85%
-15.19M
200%
-1.06M
93.00%
stock based compensation
4.78M
-
5.05M
5.67%
8.72M
72.55%
27.60M
216.55%
83.78M
203.57%
102.08M
21.84%
111.32M
9.05%
change in working capital
4.86M
-
12.49M
156.97%
8.20M
34.34%
29.52M
259.85%
-628.39M
2,228.56%
665.37M
205.88%
-304.59M
145.78%
accounts receivables
-773.08M
-
770.04M
199.61%
-565K
100.07%
inventory
52.81M
-
accounts payables
2.01M
-
1.47M
26.85%
964K
34.47%
-790K
181.95%
-171K
78.35%
797K
566.08%
732K
8.16%
other working capital
2.85M
-
11.02M
286.64%
7.24M
34.32%
30.31M
318.67%
92.04M
203.65%
-105.47M
214.59%
-304.76M
188.96%
other non cash items
4.32M
-
1.97M
54.50%
8.95M
355.32%
45.21M
405.33%
-52.56M
216.25%
388.37M
838.91%
11.16M
97.13%
net cash provided by operating activities
-66.38M
-
-94.10M
41.75%
-129.63M
37.77%
-190.94M
47.29%
-47.59M
75.08%
1.66B
3,595.04%
-778.78M
146.82%
investments in property plant and equipment
-2.74M
-
-8.19M
198.76%
-8.94M
9.13%
-6.55M
26.74%
-21.82M
233.13%
-68.03M
211.81%
-21.57M
68.29%
acquisitions net
-27.25M
-
25K
100.09%
247.22M
988,772.00%
180K
99.93%
140.81M
78,130%
22K
99.98%
100K
354.55%
purchases of investments
-123.11M
-
-643.90M
423.05%
-403.84M
37.28%
-420.24M
4.06%
-1.48B
251.46%
-2.02B
36.51%
sales maturities of investments
72.57M
-
396.68M
446.59%
400.35M
0.92%
301.24M
24.75%
351.51M
16.69%
2.20B
526.55%
other investing activites
-1.74M
-
-247.22M
14,083.48%
-140.81M
-
net cash used for investing activites
-29.99M
-
-60.44M
101.51%
-256.16M
323.81%
-9.86M
96.15%
-140.81M
1,327.84%
-1.19B
747.54%
164.73M
113.80%
debt repayment
-95K
-
-250K
163.16%
-259K
3.60%
-260K
0.39%
-287K
10.38%
common stock issued
126.41M
-
529.91M
319.20%
85.21M
83.92%
28.46M
66.60%
7.77M
72.71%
common stock repurchased
-3K
-
3.22M
-
dividends paid
other financing activites
271.18M
-
24.98M
90.79%
322.93M
1,192.86%
-189K
100.06%
15.38M
8,235.98%
3.34M
78.30%
-100K
103.00%
net cash used provided by financing activities
271.18M
-
24.98M
90.79%
449.24M
1,698.56%
529.47M
17.86%
100.33M
81.05%
34.76M
65.35%
7.38M
78.77%
effect of forex changes on cash
-7.48M
-
net change in cash
174.81M
-
-129.56M
174.12%
63.45M
148.98%
328.67M
417.97%
-88.07M
126.80%
504.55M
672.89%
-606.47M
220.20%
cash at beginning of period
14.11M
-
188.92M
1,238.54%
59.36M
68.58%
122.82M
106.89%
451.49M
267.61%
363.42M
19.51%
861.31M
137.01%
cash at end of period
188.92M
-
59.36M
68.58%
122.82M
106.89%
451.49M
267.61%
363.42M
19.51%
867.97M
138.84%
254.84M
70.64%
operating cash flow
-66.38M
-
-94.10M
41.75%
-129.63M
37.77%
-190.94M
47.29%
-47.59M
75.08%
1.66B
3,595.04%
-778.78M
146.82%
capital expenditure
-2.74M
-
-8.19M
198.76%
-8.94M
9.13%
-6.55M
26.74%
-21.82M
233.13%
-68.03M
211.81%
-21.57M
68.29%
free cash flow
-69.12M
-
-102.29M
47.98%
-138.57M
35.47%
-197.49M
42.52%
-69.41M
64.86%
1.60B
2,398.40%
-800.36M
150.17%

All numbers in (except ratios and percentages)